DH
Dr. Harald Hasselmann
Chief Executive Officer (CEO), Chairman of the Executive Board
Eckert and ZieglerTherapeutic Areas
Eckert and Ziegler Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lu-177 Supply Partnerships | Prostate Cancer, Neuroendocrine Tumors | Commercial & Clinical Support |
| Brachytherapy Product Development | Prostate, Breast, Gynecological Cancers | Ongoing R&D |
| Novel Isotope Production (e.g., Ac-225) | Various Oncology | Pre-clinical / Early Development |
| Radiopharmaceutical Precursor Kits | Diagnostic Imaging | Commercial |
Leadership Team at Eckert and Ziegler
DG
Dr. Gunnar Mann
Chief Operating Officer (COO)
FY
Frank Yeager
Chief Executive Officer, Segment Isotope Products
DD
Dr. Dirk Becker
Vice President Research & Development, Segment Medical
MS
Michael Schmitz
Vice President Sales & Marketing, Segment Medical
DA
Dr. Andreas Eckert
Chairman of the Supervisory Board